Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders, today reported its financial results for the quarter ended March 31, 2013.
http://www.biospace.com/news_story.aspx?StoryID=295294&full=1
http://www.biospace.com/news_story.aspx?StoryID=295294&full=1
No comments:
Post a Comment